PNH

Showing 2 posts of 2 posts found.

anirudh-djo3injpaoe-unsplash_3

AstraZeneca’s Voydeya approved in Japan for PNH treatment

January 19, 2024
Medical Communications AstraZeneca, Haematology, PNH, Voydeya

AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal haemoglobinuria (PNH), in …

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023
Medical Communications FDA, Fabhalta, Haematology, Novartis, PNH

Novartis has announced that the US Food and Drug Administration has approved Fabhalta (iptacopan) as the first oral monotherapy for …

The Gateway to Local Adoption Series

Latest content